Showing results (81-90 of 285) with videos related to
Sort By:
Pageof 29
Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2011
Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational studyPatrick Marcellin, Michel Chousterman, Thierry Fontanges, et al.Plos One|March 20, 2015
Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trialsTram T Tran, Stuart C Gordon, Scott Fung, et al.Gut|May 6, 2010
Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytesTony Durand, Gaëtana Di Liberto, Hélène Colman, et al.Journal of Hepatology|March 22, 2015
Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvirZobair M Younossi, Maria Stepanova, Nezam Afdhal, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2002
Auxiliary liver transplantation for fulminant hepatitis B: results from a series of six patients with special emphasis on regeneration and recurrence of hepatitis BFrançois Durand, Jacques Belghiti, Adriana Handra-Luca, et al.Gut|September 29, 2006
Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapyLiana Codes, Tarik Asselah, Dominique Cazals-Hatem, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 17, 2010
Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirinTarik Asselah, Emilie Estrabaud, Ivan Bieche, et al.Gastroenterology|June 10, 2006
Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirinValérie Paradis, Tarik Asselah, Delphine Dargere, et al.World Journal of Gastroenterology|November 6, 2008
Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: a prospective, real-life, observational studyPatrice Cacoub, Denis Ouzan, Pascal Melin, et al.Antimicrobial Agents and Chemotherapy|November 19, 2014
Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver diseaseBlaise K Kutala, Jeremie Guedj, Tarik Asselah, et al.Pageof 29